Studies have demonstrated that Healome’s formulations have anti-fibrotic activity and are augmented when combined with other therapeutics
Studies have demonstrated that Healome’s formulations have anti-fibrotic activity and are augmented when combined with other therapeutics
Infertility is estimated to affect one in seven couples across the UK and can have a profound effect on mental health
Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers
The civil servant drew attention to vaccinations falling to lowest level in a decade
The new guidelines focus on key areas of prescription, management of withdrawal and severity of withdrawal symptoms
Company at the forefront of developing personalised treatments against invasive cancer has raised 15m euros to conduct clinical trials
‘The Eyes Have It’ partnership will highlight the importance of eye health
High unmet need in the area of hepatitis B therapies will see companies share responsibilities to develop the vaccine
Protein technology could dramatically improve prospects of heart attack victims by proliferating organ cells
Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
Engitix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products